Biogenity ApS: Financial statements 2024
CVR: 39606925
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
Biogenity ApS (CVR 39606925) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,898,870 and a net result of DKK -342,877 compared with DKK 449,314 the year before. That is a decrease of 20.8% compared with the year before. Equity in the 2024 report amounted to DKK 263,887. The solvency ratio was 25%. The company had 6 employees in the financial year.
- Gross Profit
- DKK 1,898,870
- Profit/Loss
- DKK -342,877
- Equity
- DKK 263,887
- Total Assets
- DKK 1,054,240
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.9 mio. | -343 t. | 264 t. | 6 |
| 2023 | - | 2.4 mio. | 449 t. | 607 t. | 5 |
| 2022 | - | 1.3 mio. | -108 t. | 143 t. | 5 |
| 2021 | - | 97 t. | 117 t. | 250 t. | 3 |
| 2020 | - | -115 t. | 72 t. | 133 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout Biogenity ApS
Biogenity ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kenneth Kastaniegaard and Louis Loeb. The board consists of Louis Loeb (chair) and Kenneth Kastaniegaard. The company is owned by L.Loeb Holding ApS and Kastaniegaard Holding ApS. According to the 2025 annual report, the company had an average of 4 employees. In 2025, the company reported a gross profit of DKK 1,387,873 and a net result of DKK -453,753 compared with DKK -342,877 the year before. Equity in the 2025 report amounted to DKK -189,867.